Procaps Group (NASDAQ:PROC) Trading Down 3%

Procaps Group S.A. (NASDAQ:PROC) shares dropped 3% during mid-day trading on Thursday . The stock traded as low as $2.59 and last traded at $2.60. Approximately 9,167 shares changed hands during mid-day trading, a decline of 57% from the average daily volume of 21,215 shares. The stock had previously closed at $2.68.

Procaps Group Stock Performance

The company has a current ratio of 1.47, a quick ratio of 0.99 and a debt-to-equity ratio of 5.74. The firm has a market cap of $293.33 million, a P/E ratio of 5.00 and a beta of 0.13. The company’s 50-day moving average is $3.06 and its two-hundred day moving average is $3.21.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Millennium Management LLC grew its position in Procaps Group by 15.9% during the second quarter. Millennium Management LLC now owns 101,430 shares of the company’s stock worth $945,000 after buying an additional 13,908 shares in the last quarter. Exome Asset Management LLC bought a new stake in Procaps Group during the fourth quarter valued at approximately $516,000. Citadel Advisors LLC purchased a new position in Procaps Group in the 2nd quarter worth approximately $263,000. Geode Capital Management LLC lifted its holdings in shares of Procaps Group by 13.7% during the 1st quarter. Geode Capital Management LLC now owns 21,223 shares of the company’s stock worth $96,000 after acquiring an additional 2,562 shares during the last quarter. Finally, State Street Corp purchased a new stake in Procaps Group during the third quarter valued at about $89,000.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.